BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21894011)

  • 1. Requirements and challenges of a preclinical autoimmune hepatitis mouse model.
    Hardtke-Wolenski M; Noyan F; Jaeckel E
    Dig Dis; 2011; 29(4):402-10. PubMed ID: 21894011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models for experimental autoimmune hepatitis: limits and chances.
    Hardtke-Wolenski M; Jaeckel E
    Dig Dis; 2010; 28(1):70-9. PubMed ID: 20460893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for autoimmune liver disease--what is relevant for immune-mediated liver disease.
    Hardtke-Wolenski M; Taubert R; Jaeckel E
    Dig Dis; 2012; 30 Suppl 1():2-10. PubMed ID: 23075863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of autoimmune hepatitis.
    Jaeckel E
    Semin Liver Dis; 2002 Nov; 22(4):325-38. PubMed ID: 12447705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of animal models for autoimmune hepatitis.
    Jaeckel E; Hardtke-Wolenski M; Fischer K
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):643-51. PubMed ID: 22117631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New animal models for autoimmune hepatitis.
    Christen U; Hintermann E; Jaeckel E
    Semin Liver Dis; 2009 Aug; 29(3):262-72. PubMed ID: 19675999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
    Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells.
    Hardtke-Wolenski M; Fischer K; Noyan F; Schlue J; Falk CS; Stahlhut M; Woller N; Kuehnel F; Taubert R; Manns MP; Jaeckel E
    Hepatology; 2013 Aug; 58(2):718-28. PubMed ID: 23475565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis.
    Lapierre P; Béland K; Alvarez F
    Transl Res; 2007 Mar; 149(3):107-13. PubMed ID: 17320796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.
    Czaja AJ; Manns MP
    Gastroenterology; 2010 Jul; 139(1):58-72.e4. PubMed ID: 20451521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for autoimmune hepatitis.
    Christen U; Holdener M; Hintermann E
    Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry.
    Piché C; Béland K; Lapierre P; Massie B; Alvarez F
    Liver Int; 2011 Oct; 31(9):1306-14. PubMed ID: 22093453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
    Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
    J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hepatitis, HLA and extended haplotypes.
    Oliveira LC; Porta G; Marin ML; Bittencourt PL; Kalil J; Goldberg AC
    Autoimmun Rev; 2011 Feb; 10(4):189-93. PubMed ID: 20933106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis.
    Suzuki Y; Kobayashi M; Hosaka T; Someya T; Akuta N; Kobayashi M; Suzuki F; Tsubota A; Saitoh S; Arase Y; Ikeda K; Matsuda M; Sato J; Miyakawa Y; Kumada H
    J Gastroenterol; 2004 Jul; 39(7):649-53. PubMed ID: 15293135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.